Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus

被引:62
作者
Hatano, K [1 ]
Morishita, Y [1 ]
Nakai, T [1 ]
Ikeda, F [1 ]
机构
[1] Fujisawa Pharmaceut Co Ltd, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan
关键词
D O I
10.7164/antibiotics.55.219
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:219 / 222
页数:4
相关论文
共 13 条
[11]   W-1 SOLUBILIZATION AND KINETICS OF INHIBITION BY CILOFUNGIN OF CANDIDA-ALBICANS (1,3)-BETA-D-GLUCAN SYNTHASE [J].
TANG, J ;
PARR, TR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :99-103
[12]   In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi [J].
Tawara, S ;
Ikeda, F ;
Maki, K ;
Morishita, Y ;
Otomo, K ;
Teratani, N ;
Goto, T ;
Tomishima, M ;
Ohki, H ;
Yamada, A ;
Kawabata, K ;
Takasugi, H ;
Sakane, K ;
Tanaka, H ;
Matsumo, F ;
Kuwahara, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :57-62
[13]  
Wade James C., 1997, Leukemia (Basingstoke), V11, pS38